Fibronostics US
Latest round
- Series A
Last raised
- Aug 2020
Total raised
- $7.9M
Investors
- 4
About Fibronostics US
Fibronostics US, Inc.Founded in 2015 and headquartered in Indian Harbour Beach, US, Fibronostics US, Inc. focuses on developing innovative diagnostic solutions.Fibronostics specializes in noninvasive medical diagnostics, offering innovative solutions that leverage artificial intelligence and advanced analytics to assess liver health.00, reflecting the patient's fibrosis, activity, and steatosis staging. This test is designed to provide healthcare professionals and patients with vital information about liver conditions without the need for invasive procedures like biopsies. The product has been validated by leading clinicians and is applicable for various demographics, including individuals with metabolic diseases such as MASH and MASLD.Fibronostics generates revenue primarily through the sale of its flagship diagnostic test, LIVERFASt™, offered to healthcare providers such as hospitals, clinics, and individual practitioners. The transactions typically occur on a B2B basis, where physicians prescribe the LIVERFASt™ test to patients, and the company processes the blood samples in its CAP and CLIA-certified laboratory. Results are delivered to healthcare providers via a digital portal or integrated systems.In June 2022, Fibronostics US, Inc.S. and help develop its SaaS platform, as well as finance the research and development of new products targeting kidney and lung diseases., with specific target markets yet to be disclosed.
Who invested in Fibronostics US
4 investors across 1 round
See all investors in Fibronostics US
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Aug 21, 2020
Amount
$7.9M
Investors
Questions about Fibronostics US
Who invested in Fibronostics US?
Fibronostics US has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Fibronostics US raised?
Fibronostics US has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Fibronostics US last raise money?
Fibronostics US's most recent round on record is a Series A, in Aug 2020.
What does Fibronostics US do?
Fibronostics US is a healthcare it company.
Where is Fibronostics US headquartered?
Fibronostics US is headquartered in Indian Harbour Beach, US.
Which VCs invest in companies like Fibronostics US?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back healthcare it companies at Fibronostics US's stage. Their profiles are linked below.
VCs backing healthcare it startups at Series A
Raising like Fibronostics US? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.